GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Chemed Corp (NYSE:CHE) » Definitions » Cyclically Adjusted Revenue per Share

CHE (Chemed) Cyclically Adjusted Revenue per Share : $145.84 (As of Mar. 2025)


View and export this data going back to 1972. Start your Free Trial

What is Chemed Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Chemed's adjusted revenue per share for the three months ended in Mar. 2025 was $43.819. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $145.84 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Chemed's average Cyclically Adjusted Revenue Growth Rate was 6.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.40% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 9.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Chemed was 14.00% per year. The lowest was -4.00% per year. And the median was 8.60% per year.

As of today (2025-06-29), Chemed's current stock price is $559.36. Chemed's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was $145.84. Chemed's Cyclically Adjusted PS Ratio of today is 3.84.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.87. And the median was 3.98.


Chemed Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Chemed's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemed Cyclically Adjusted Revenue per Share Chart

Chemed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.62 112.35 124.31 133.45 142.48

Chemed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 137.14 139.20 141.00 142.48 145.84

Competitive Comparison of Chemed's Cyclically Adjusted Revenue per Share

For the Medical Care Facilities subindustry, Chemed's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemed's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Chemed's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Chemed's Cyclically Adjusted PS Ratio falls into.


;
;

Chemed Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Chemed's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=43.819/134.9266*134.9266
=43.819

Current CPI (Mar. 2025) = 134.9266.

Chemed Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 21.926 100.684 29.383
201509 22.169 100.392 29.795
201512 22.910 99.792 30.976
201603 22.737 100.470 30.535
201606 23.196 101.688 30.778
201609 23.710 101.861 31.407
201612 24.301 101.863 32.189
201703 24.157 102.862 31.687
201706 25.925 103.349 33.846
201709 25.033 104.136 32.435
201712 25.682 104.011 33.316
201803 26.007 105.290 33.328
201806 26.281 106.317 33.353
201809 26.482 106.507 33.548
201812 27.360 105.998 34.827
201903 27.960 107.251 35.175
201906 28.791 108.070 35.946
201909 29.031 108.329 36.159
201912 31.530 108.420 39.238
202003 31.230 108.902 38.693
202006 30.672 108.767 38.049
202009 32.266 109.815 39.644
202012 32.647 109.897 40.083
202103 32.334 111.754 39.038
202106 33.057 114.631 38.910
202109 34.002 115.734 39.641
202112 34.895 117.630 40.026
202203 34.923 121.301 38.846
202206 35.159 125.017 37.946
202209 35.000 125.227 37.711
202212 36.313 125.222 39.127
202303 37.072 127.348 39.278
202306 36.390 128.729 38.142
202309 37.140 129.860 38.589
202312 38.380 129.419 40.013
202403 38.414 131.776 39.332
202406 39.072 132.554 39.771
202409 39.964 133.029 40.534
202412 42.709 133.157 43.277
202503 43.819 134.927 43.819

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Chemed  (NYSE:CHE) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Chemed's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=559.36/145.84
=3.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Chemed was 5.50. The lowest was 1.87. And the median was 3.98.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Chemed Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Chemed's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemed Business Description

Industry
Traded in Other Exchanges
Address
255 East Fifth Street, Suite 2600, Cincinnati, OH, USA, 45202-4726
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Executives
Spencer S Lee officer: vice president 2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Kevin J Mcnamara director, officer: president & ceo 2500 CHEMED CENTER, 255 EAST FIFTH ST, CINCINNATI OH 45202
Brian C Judkins officer: VP and Chief Legal Officer 255 EAST FIFTH STREET, SUITE 2600, CINCINNATI OH 45202
Walsh George J Iii director ONE CHASE MANHATTAN PLAZA, NEW YORK NY 10005
Nicholas Michael Westfall officer: Executive Vice President 8035 PEREGRINE LANE, CINCINNATI OH 45243
Andrea R Lindell director
Thomas C Hutton director, officer: vice president ONE ROCKEFELLER PLAZA, STE 1510, NEW YORK NY 10020
Patrick P Grace director 1100 PARK AVE, APT 15C, NEW YORK NY 10128
Michael D Witzeman officer: vice president and controller 255 E 5TH STREET, SUITE 2600, CINCINNATI OH 45202
David Patrick Williams officer: Vice President & CFO
Eileen P Mccarthy director 3515 78TH STREET, #2, JACKSON HEIGHTS NY 11372
Mount John Meredith Jr. director 2906 MABRY ROAD NE, ATLANTA GA 30319
Donald E Saunders director 306 MIANI TRAIL, OXFORD OH 45056
Christopher J Heaney director 101 S. FORT LAUDERDALE BEACH BLVD., APARTMENT 1602, FORT LAUDERDALE FL 33316
Ron Delyons director 2692 MADISON ROAD, SUITE N1-313, CINCINNATI OH 45208